Evaluation of risk factors of disease progression in HIV-infected patients with relapses of pulmonary tuberculosis

Authors

  • R. M. Yasinskiy Zaporizhzhia State Medical University,

DOI:

https://doi.org/10.14739/2310-1237.2016.1.71187

Keywords:

Tuberculosis, HIV, Coinfection, Risk Factors, Disease Progression

Abstract

There are no defined risk factors for progression of TB in HIV-positive patients with relapses of pulmonary tuberculosis (RTB/HIV) nowadays. In order to identify the risk factors of disease progression 23 patients with RTB/HIV were examined; we determined complex influence of clinical, radiological, immunological and laboratory parameters on the progression of TB.

We determined the following risk factors: the presence of systemic inflammatory response syndrome, massive bacterial excretion, multiple destructive process in the lungs, reducing the number of CD4+-cells < 200 cells/mm ("large criteria"). Each "large criterion" is estimated at one point. To enable the laboratory data as predicting disease progression criteria in patients with RTB/HIV the simultaneous presence of any 3-of-9 indicators that relate to "small criteria" is necessary in patients (reduction of Hb level <110 g/l, decreased lymphocyte count <20%, decreased hematocrit <35 units., increased leukocyte intoxication index >2.0 units, decreased lymphocyte level <0.25 units, the presence of C-reactive protein in the blood, fibrin level 9> and <18 g/l, albumin level reduction <40%, reduction of albumins/globulins <0.7 units). In this case each "small criterion" we estimate at 1 point. To determine the progressive course minimum number of points (1 out of 5) is necessary.

References

Babich, P. N., Chubenko, A. V., & Lapach, S. N. (2005). Primenenie sovremennykh statisticheskikh metodov v praktike klinicheskikh issledovanij. Soobschenie tret'e. Otnoshenie shansov: ponyatie, vychislenie i interpretaciya [Use of modern statistical methods in the practice of clinical research. Report three. The odds ratio: definition, calculation and interpretation]. Ukrainskyi medychnyi chasopys, 2(46), 113–119. [in Ukrainian].

Borodin, E. A., Egorshina, E. V., & Samsonov, V. P. (2003). Biokhimiya e′ndotoksikoza. Mekhanizmy razvitiya i ocenka stepeni tyazhesti pri vospalitel′nykh zabolevaniyakh legkikh [Biochemistry of endotoxicosis. Mechanisms of development and severity estimation of inflammatory lung diseases]. Blagoveshchensk : AGMA. [in Russian].

Korzh, O. V., Trunova, O. A., Mozgovyj, V. V., Pavjenko, O. V., Chursina, N. S., & Uzun, I. P. (2013). Hematolohichni ta biokhimichni rozlady u khvorykh na ko-infektsiiu tuberkuloz/VIL z riznym stanom imunitetu [Hematologic and biochemical disorders in TB/HIV co-infected patients in different states of immunity]. Tuberkuloz, legenevi hvoroby, VIL-infektsiia, 1, 51–56. [in Ukrainian].

Haertynova, I. M., Valiev, R. Sh., Сibul′kin, A. P., Valiev, N. R., Hamzina, R. V., Lazarenko, O. G., & Romanenko, S. E′. (2009). Kliniko-immunologicheskie osobennosti VICH-infekcii, sochetannoj s tuberkulezom [Clinical and immunological features of HIV infection, combined with tuberculosis]. Problemy tuberkuleza i boleznej legkikh, 86(6), 41–46. [in Russian].

Kaminskaya, G. O., Abdullaev, R. Yu., Martynova, E. V., Serebryanaya, B. A., & Komissarova, O. G. (2009). [Systemic inflammatory response syndrome at a pulmonary tuberculosis]. Problemy tuberkuleza i boleznej legkih, 11, 40–48. [in Russian].

Cain, K. P., McCarthy, K. D., Heilig, C. M., Monkongdee, P., Tasaneeyapan, T., Kanara, N., et al. (2010). An algorithm for tuberculosis screening and diagnosis in people with HIV. The New England journal of medicine, 362(8), 707–716. doi: 10.1056/NEJMoa0907488.

Carugati, M., Schiroli, C., Zanini, F., Vanoni, N., Galli, M., Adorni, F., & Franzetti, F. (2014). A new predictive model for an improved respiratory isolation strategy in HIV-infected patients with PTB. The international journal of tuberculosis and lung disease, 18(7), 831–836. doi: 10.5588/ijtld.13.0588.

Houben, R. M. G. J. D., Dowdy, W., Vassall, A., Cohen, T., Nicol, M. P., Granich, R. M., et al. (2014). How can mathematical models advance tuberculosis control in high HIV prevalence settings? Int J Tuberc Lung Dis, 18(5), 509–514. doi: 10.5588/ijtld.13.0773.

Shah, S., Demissie, M., Lambert, L., Ahmed, J., Leulseged, S., Kebede, T., et al. (2009). Intensified tuberculosis case finding among HIV-infected persons from a voluntary counseling and testing center in Addis Ababa, Ethiopia. Journal of acquired immune deficiency syndromes, 50(5), 537–545. doi: 10.1097/QAI.0b013e318196761c.

Shah, R. P., Pawar, G. B., & Bhiwgade, D. A. (2009). Analysis of adenosine deaminase enzyme in HIV and tuberculosis in Indian population. International Journal of Biotechnology Applications, 1(2), 32–40.

How to Cite

1.
Yasinskiy RM. Evaluation of risk factors of disease progression in HIV-infected patients with relapses of pulmonary tuberculosis. Pathologia [Internet]. 2016Jun.23 [cited 2024Apr.16];(1). Available from: http://pat.zsmu.edu.ua/article/view/71187

Issue

Section

Original research